darkrose2000
05-25-2013, 12:36 PM
PROUD Study - Take part of research to reduce your risk of HIV
Examining the impact on gay men of using Pre-Exposure Prophylaxis (PrEP)
What is PrEP?
PrEP (Pre-Exposure Prophylaxis) is a new way to reduce the risk of getting HIV. It involves HIV negative people taking a daily tablet that contains drugs commonly used to treat HIV.
PROUD is a two-year study to recruit volunteers across England, who will be placed at random into one of two groups. One group will use PrEP from the start of the study, and the other group will receive PrEP after 12 months.
Truvada (which contains tenofovir and emtricitabine, also called FTC) is used in this study. Truvada is already widely used and any side effects are usually mild.
Previous studies with gay men found that using PrEP almost halved HIV infections – and there were even fewer infections amongst men who took their pill every day.
The two-year study will recruit volunteers across England, who will be placed at random into one of two groups. One group will use PrEP from the start of the study, and the other group will receive PrEP after 12 months. Both groups will receive support to remain HIV negative throughout the study.
Participants are asked to keep a short daily diary, fill out a monthly questionnaire and attend a clinic appointment every three months.
This study is looking at a new way to reduce the risk of getting HIV. It will look at the impact of taking PrEP on how often men have sex; how often they use condoms; and whether they get other sexually transmitted infections.
Why take part?
The study will give us more information about how PrEP could be used to prevent new HIV infections amongst gay men / transgender women.
By taking part, you could reduce your own risk of catching HIV.
Our team will help and support you to be healthy.
You can take part in the study if you:
Are HIV negative
Are 18 or older
Have had anal sex without a condom in the last three months.
Are likely to do this again in the next three months.
Can visit the clinic for blood tests every three months.
To find out more, click here for the Participant Information Sheet.
The PROUD study protocol is available here - this is quite lengthy reading; you might want to email any questions to PROUD@ctu.mrc.ac.uk or contact your local clinic to clarify anything.
If you are interested in taking part, either email or speak to a health advisor or doctor at one of the recruiting clinics in person. There are sites in London, Brighton, York, Manchester, Sheffield and Birmingham. Click here for more information and contact details.
Source: http://www.proud.mrc.ac.uk/
Examining the impact on gay men of using Pre-Exposure Prophylaxis (PrEP)
What is PrEP?
PrEP (Pre-Exposure Prophylaxis) is a new way to reduce the risk of getting HIV. It involves HIV negative people taking a daily tablet that contains drugs commonly used to treat HIV.
PROUD is a two-year study to recruit volunteers across England, who will be placed at random into one of two groups. One group will use PrEP from the start of the study, and the other group will receive PrEP after 12 months.
Truvada (which contains tenofovir and emtricitabine, also called FTC) is used in this study. Truvada is already widely used and any side effects are usually mild.
Previous studies with gay men found that using PrEP almost halved HIV infections – and there were even fewer infections amongst men who took their pill every day.
The two-year study will recruit volunteers across England, who will be placed at random into one of two groups. One group will use PrEP from the start of the study, and the other group will receive PrEP after 12 months. Both groups will receive support to remain HIV negative throughout the study.
Participants are asked to keep a short daily diary, fill out a monthly questionnaire and attend a clinic appointment every three months.
This study is looking at a new way to reduce the risk of getting HIV. It will look at the impact of taking PrEP on how often men have sex; how often they use condoms; and whether they get other sexually transmitted infections.
Why take part?
The study will give us more information about how PrEP could be used to prevent new HIV infections amongst gay men / transgender women.
By taking part, you could reduce your own risk of catching HIV.
Our team will help and support you to be healthy.
You can take part in the study if you:
Are HIV negative
Are 18 or older
Have had anal sex without a condom in the last three months.
Are likely to do this again in the next three months.
Can visit the clinic for blood tests every three months.
To find out more, click here for the Participant Information Sheet.
The PROUD study protocol is available here - this is quite lengthy reading; you might want to email any questions to PROUD@ctu.mrc.ac.uk or contact your local clinic to clarify anything.
If you are interested in taking part, either email or speak to a health advisor or doctor at one of the recruiting clinics in person. There are sites in London, Brighton, York, Manchester, Sheffield and Birmingham. Click here for more information and contact details.
Source: http://www.proud.mrc.ac.uk/